Medication-related cognitive impairment is common, mimics neurodegenerative disease, increases with polypharmacy, and may be prevented with regular cognitive assessment monitoring.

Engaging in a simple home-based exercise regimen of walking and resistance training during chemotherapy can help patients ...

At the 20th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) in ...

(Smile/Getty Images) Early signs of Alzheimer's disease may be hidden in the way a person speaks, but it's not yet clear ...

Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of cognitive impairment, with a notably higher likelihood of developing non-amnestic mild cognitive impairment.

A recent study published in the journal GeroScience suggests that a person’s overall physical and mental reserve can predict ...

The risk for future incident mild cognitive impairment or dementia in older women was elevated with higher levels of plasma ...

Cognitive impairment, commonly referred to as “chemobrain”, is a multifaceted condition experienced by many breast cancer survivors. It encompasses deficits in memory, processing speed, attention and ...

Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development ...